Bearish
[Form 4] Monte Rosa Therapeutics, Inc. Insider Trading Activity
Monte Rosa Therapeutics President & CEO Markus Warmuth reported an open-market sale of 8,000 shares of Common Stock on April 14, 2026, at a weighted a...